Scientists at Gladstone Institutes and UCSF have turned to computational shortcuts to find Alzheimer’s treatments among drugs ...

The drug industry has been working on how to shuttle drugs through the blood-brain barrier, and the results will become ...

Amyloid is increasingly ceding ground in Alzheimer’s disease R&D to new approaches targeting inflammation, immune processes, ...

Penn Holderness, a family influencer, has the highest genetic risk for Alzheimer's. He started taking a GLP-1 solely to ...

A variety of Alzheimer’s medications can help manage different symptoms and improve quality of life as the disease progresses. Alzheimer’s medications help manage symptoms by improving memory, ...

The Lancet World Report examines why regulators in the US, UK, and Europe have reached different decisions on new ...

Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...

An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved ...

DAVENPORT, Iowa — While millions of people struggle with Alzheimer's disease, no approved treatment is available, however, a new drug awaiting FDA approval could prevent the early onset of the disease ...

The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.

Alzheimer's advocate urges lawmakers to support ASAP Act, allowing Medicare to cover blood tests for Alzheimer's disease.

HARTFORD, CT (WFSB) - Important health advocacy is happening at the state capitol right now. Alzheimer’s advocates are pushing for changes that would make testing and medication readily available and ...